Branded for Failure? Industry Hesitant to Adopt FDA Brand Name Review Pilot
This article was originally published in RPM Report
Executive Summary
FDA wants industry to endorse a pilot program that would make sponsors responsible for testing proposed brand names for medication errors. Industry is concerned the process will make reviews less predictable. But sponsors should ask themselves this: what's less predictable than the current 40% rejection rate?